Clever Leaves EV/EBIT
Cos'è EV/EBIT di Clever Leaves?
EV/EBIT di Clever Leaves Holdings Inc. è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Clever Leaves
Cosa fa Clever Leaves?
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Aziende con ev/ebit simili a Clever Leaves
- TV Vision ha EV/EBIT di N/A
- NextTrip ha EV/EBIT di N/A
- Cor Infrastructure Trust Inc ha EV/EBIT di N/A
- Entera Bio Ltd ha EV/EBIT di N/A
- Sensyne Health plc ha EV/EBIT di N/A
- Tocagen ha EV/EBIT di N/A
- Clever Leaves ha EV/EBIT di N/A
- Ucommune International Ltd ha EV/EBIT di N/A
- Ashford Inc ha EV/EBIT di N/A
- Akerna Corp ha EV/EBIT di N/A
- ThreeD Capital ha EV/EBIT di N/A
- Surgalign ha EV/EBIT di N/A
- Regulus Therapeutics Inc ha EV/EBIT di N/A